Summary.-The relationships between DNA damage from UV radiation, alkylating drugs and the methylated xanthines (MX) have been studied in normal and malignant rodent and human cells. A comparison of the level of DNA excision repair (repair replication and unscheduled DNA synthesis) confirms that some forms of alkylatingagent damage (probably mono-filar DNA adducts) are less completely removed by both normal and malignant rodent cells than by their human counterparts, rendering rodent cells more susceptible to the toxic potential of unexcised lesions. The toxicity of alkylating agents canbe increased by the presence of several MXs during the period of DNA replication which follows infliction of the damage. Human cells appear capable of excising more DNA damage, rendering them somewhat less susceptible to enhancement of cytotoxicity by MX. This resistance of human cells is only quantitative, however, since 2 human cancer cell lines (HeLa and HT-29) could be sensitized to a variety of alkylating agents by appropriate concentrations of MX. Trimethylxanthine (caffeine) and the 2 clinically useful dimethylxanthines (theophylline and theobromine) appeared equally effective in sensitizing cells. The sensitization was dependent upon a slightly cytotoxic concentration of the MX and a suitably prolonged period of post-damage MX exposure. Of these 3 classic MXs, only theobromine might be clinically useful. The levels required for alkylating-agent sensitization exceed the clinically tolerable level of theophylline, and probably approach the tolerance of man to caffeine. The most likely mechanism by which MX sensitization is achieved is reversal of the inhibition of DNA replicon initiation which follows the infliction of significant DNA damage. Through the selection of suitable clinically useful alkylating agents (those dependent on active cellular transport for cell penetration) and appropriate MX scheduling, an enhanced therapeutic ratio might be achieved, potentially increasing the clinical usefulness of these alkylating agents. MX would thus form a useful class of agents adjuvant to conventional anticancer drugs.
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DESPITE THE GROWING VOLUME of agents, or from a more effective use of cancer treatment research in the world already established single agents. today, effective treatment for many human Perhaps the most paradoxical clinical cancers is not yet available. Improve-observation is that tumours that grow ments in cancer chemotherapy currently most rapidly are often the most sensitive appear to offer the most promise. Such to chemotherapy. This might be expected improvements could result from new for chemotherapeutic regimens utilizing drugs, better combinations of existing antimetabolites that affect DNA synCorrespondence to: Dr John Byfield, Division of Radiation Oncology, University Hospital, 225 Dickinson Street, San Diego, Calif., U.S. A. 92103. 46 thesis, but it is not at all apparent why other regimens are also more effective against the rapidly proliferating cancers. Whatever the source of this differential activity, it seems likely to involve the exposure of the cell to DNA damage during S phase. Accordingly, agents which enhance the S-phase-dependent damage of existing drugs may be useful. One means of increasing the cells' sensitivity to S-phase damage would be to render sublethal damage more toxic. This might be done by increasing or prolonging the intracellular level of active drug, by blocking the capacity of the cell to repair the drug's damage, or by interfering with other survival measures (such as replication delay) instituted by the cell during this critical period. Evidence is presented in this paper to suggest that methylated xanthines (MX) may be useful by means of the latter mechanism. Because of the complicated literature extant on MX, a brief review of their status in this perspective is warranted.
The MXs are compounds like caffeine, theophylline and theobromine ( Fig. 1 (Boyce & Howard Flanders, 1964; Setlow & Carrier, 1964) . Most human cells can remove many such dimers by enzymatic means (called excision repair) but cells from many patients with the hereditary disease xeroderma pigmentosum (XP) cannot (Cleaver, 1968) . Such XP cells are uniquely sensitive to UV radiation (Cleaver, 1974) . On the other hand, cultured (that is, passaged) rodent cells show a very limited capacity to remove UV-induced dimers (Cleaver, 1974 ). Yet such rodent cells are not intrinsically more sensitive to UV than are human cells. The reason for this appears to be the capacity of rodent cells to bypass UVinduced dimers and grow despite their Theophylline Paraxanthine Fic. 1. The clhemical structure of the methylated xanthines and some relatecl compoundls (after Goodman & Gillman, 1975) . The positions of the methyl groups on these oxypurines dictate their plhysiological effects, whilst sensitization of alkylating agents appears largely independent of the ethyl gIrolup position, save at the N-3 position, where a methyl group appears obligatory. (Cleaver, 1974; Lehmann, 1974) . The gaps are thought to occur opposite the UVinduced dimers, and the process has been called "post-replication repair" (Lehmann, 1974) .
The most widespread MX, caffeine ( Fig. 1 (Cleaver, 1974) they might be anticipated to be more sensitive to this caffeine effect, as is known to be the case (Rauth, 1967) . Most human cells (which are competent to remove UV dimers) are not sensitized easily to UV by equivalent levels of MX (Wilkinson et al., 1970; Maher et al., 1975) although certain unique human mutant cells (XP "variants") are affected (Maher et al., 1976) . So-called "normal" human XP cells (i.e. those (Rauth et al., 1970; Roberts & Ward, 1973; Walker & Reid, 1971) , suggesting a common step in UV and alkylating-agent repair. However, the available studies of the effects of MX on human cells are not consistent, some showing no sensitization to alkylating agents (Roberts & Ward, 1973) or UV (Wilkinson et (WRC) , and REQ cell lines have been described (Byfield et al., 1976 (Byfield et al., , 1977 . The mouse glioma C-6 line was obtained from Dr H. Herschman. Human colonic carcinoma HT-29 cells were a gift of Dr J. Fogh. All cell lines were grown in McCoy's 5A modified medium (Byfield et al., 1976 (Byfield et al., , 1977 supplemented with 20% calf serum.
For studies of unscheduled DNA synthesis, human peripheral lymphocytes were isolated by the Ficoll-Hypaque method (Perper et al., 1968) (Byfield et al., 1977 , second method). Identical amounts of cellular DNA on each gradient permit visual semi-quantitation of radiation effects on normal and repair DNA synthesis. To evaluate the induction of unscheduled DNA synthesis, human peripheral lymphocytes or normal rat spleen cells were isolated as described above and resuspended in full McCoy's medium. They were then exposed to 3H-thymidine ([3H]-dT) as indicated in Table I after exposure to either UV (1000 erg/mm3) or alkylating agent (peroxycyclophosphamide or phosphoramide mustard), both at 10 jug/ml. In the case of UV the [3H]-dT was added immediately after UV exposure, and the cells washed free of label after 6 or 12 h labelling. For the drug exposures the dT was added coincidentally with the drug at the initiation of the labelling period and the cells washed and processed for autoradiography after 6 or 12 h. Note that the drug is in theory present throughout the period of DNA repair synthesis, and that these are unstimulated lymphocytes in both cases. Following labelling the cells were washed x 3 in HBSS, smeared, and evaluated for [3H]-dT uptake by conventional autoradiographic (emulsion) procedures. Heavily labelled (S-phase) cells were rare (less than 0-1%) and were not scored. All cells having greater than background label were considered positive for unscheduled DNA synthesis at the time of scoring. In each case the percentage labelled cells was determined after an appropriate emulsion exposure period following preliminary experiments which indicated that over 90% of those cells ultimately labelled had become so.
RESULTS

UV-induced repair replication in various cell lines
The induction of excision repair by exposure to UV light (1000 erg/mm 2) is Cells were isolated and then exposed to either peroxycyclophosphamide or phosphoramide mustard for 6 or 12 h coincidentally with [3H]-dT. UV controls were irradiated over about 10 min but exposed to [3H]-dT for 6 or 12 h. Untreated controls showed a slight increase in labelling after the longer exposure, presumably due to repair of 3H damage. (Maher et al, 1976) .
Induction of unscheduled DNA synthesis by U V and cyclophosphamide in normal human and rat cells Table I indicates the level of induction of unscheduled DNA synthesis, which may be considered equivalent to excision repair of DNA, in normal human peripheral lymphocytes and normal rat spleen cells. The cells were exposed to either UV (1000 erg/mm2) or to one of 2 forms of preactivated cyclophosphamide (peroxycyclophosphamide and phosphoramide mustard). In each case the percentage of labelled cells was evaluated after both a 6h and a 12h exposure. In a manner similar to that for long-cultured HeLa cells, the human lymphocytes showed a significant increase in unscheduled DNA synthesis when exposed to either UV or alkylating agent. The absolute number of human cells showing unscheduled DNA synthesis was in each case about twice that found in the rat cells. In the case of UV radiation this was not merely attributable to a delay in the rate of repair, since there was little difference between the 6h atud 12h labelling; i.e. plateau had been reached for both human and rat cells. On the other hand, during the 6-12h exposure to the alkylating agents, repair continued, but in each case was greater for the human lymphocytes. This indicates that continuing damage is most probably being exerted by the 2 cyclophosphamide derivatives in culture, much as occurs in vivo. In each case, however, the induction of unscheduled DNA synthesis is significantly greater in the human cells. Since the intracellular nucleotide pools may be very different in these 2 different sources of lymphoid cells, the data are at best semi-quantitative. However, it would seem that at least part of the enzymatic repair pathways for UV and cyclophosphamide are similar in these normal human and rodent cells. Thus, even non-malignant and non-passaged rodent cells may be deficient in the removal of both alkylating agent and UV damage when studied in this way.
Sensitivity of HeLa and JWVRC cells to activated cyclophosphamide Fig. 4 shows the survival curves of HeLa and WRC cells exposed to peroxycyclophosphamide. Following a 30min exposure to the drug (Fig. 4, left) , the initial level of cell killing at low concentrations is about equal in the 2 cell lines, but at higher concentration there is a dramatic increase in killing of WRC cells. Fig. 4 Fig. 9 , where the enhancement by caffeine of nitrogen mustard (NH2) toxicity against HT-29 cells is illustrated. To reach full expression, the MX needs to be present for about one cell cycle or longer (> 24 h). This timedependence is essentially the same as has been shown repeatedly for MX sensitization of cells to UV killing (cf. Roberts, 1978) .
DISCUSSION
The literature on MXs, and caffeine in particular, is immense and cannot be adequately reviewed in this context. Several recent reviews are recommended (Kihlman, 1974; Roberts, 1978; Timson, 1975) . Although there are many discordant reports available in the literature, there seems to be a general agreement that the 3 commonest MXs (caffeine, theophylline, and theobromine) have some unique effects on the repair of DNA damage by several forms of toxic agents, and when these "repair" effects are manifest there is a decrease in cell survival (i.e. sensitization). It is almost universally accepted that cultured rodent lines can be sensitized to UV by these methylated xanthines, most prominently caffeine (Roberts, 1978) . There is also agreement that cultured rodent lines can be sensitized to alkylating agents by MX (Rauth et al., 1970; Roberts, 1978) . As cultured, but not normal (Bowden et al., 1975 ) rodent lines appear universally deficient in the excision repair of UV damage, it is apparent that for these cells to achieve clonogenicity they must be able to bypass the UV-induced thymine dimers which remain in place. Thus, such cells are presumed capable of some form of "post-replication repair", an operational definition in which repair per se is defined as resumption of "normal" DNA synthesis (Lehmann, 1974) . On the other hand, there are human XP "variants", whose cells are competent of UV-excision repair replication, but seem to be deficient in post-replication repair, and such cells are also sensitized (Maher et al., 1976) to UV by MX. Thus XP "variants" resemble rodent cells in their sensitivity to MX despite the presence of enzymatic repair. Beyond these common features there is no agreement over the effects of MX on the survival of cells, especially human cells, after exposure to alkylating agents.
In a series of elegant experiments, Roberts and colleagues have shown that V79 cells were sensitized to a variety of alkylating agents when exposed to caffeine (Roberts et al., 1974; Roberts, 1978) . In their experiments, however, HeLa cells did not appear to be sensitized. At the chromosome level, Kihlman et al. (1974, no data given) found no caffeine effect for human chromosome damage. Mourelatos (1979) found that caffeine enhanced sisterchromatid exchange in human lymphocytes exposed to thiotepa. The data shown here agree with those of Roberts et al. for rodent cells but differ for HeLa cells. Since HeLa strains have been shown to differ 10-fold in their sensitivity to alkylating agents (Baker et al., 1979) , some inconsistencies in these types of experiments can be anticipated. Moreover, other recent experiments in the laboratories with a variety of MX analogues suggest that cell strains most sensitive to MX toxicity per se show relatively less capacity to be "sensitized" because MX cytotoxicity overshadows the MX-alkylating agent interaction (Murnane, 1980) . These latter observations probably explain the variations noted with different HeLa strains.
In comparing these types of experiment it would appear that the level of MX used is critical. In all our experiments a slight MX cytotoxicity was needed to obtain sensitization. When there is substantial killing by MX, sensitization is dramatic (e.g. Fig. 7) . From the standpoint of clinical application it seems likely that relatively high levels of MX would be required, and therefore slight clinical cytotoxicity (as opposed to physiological toxicity) from the MX may be a prerequisite for clinical sensitization by the drugs. Thus, empirically, a dose of MX giving slight marrow depression and/or gastrointestinal toxicity would probably be required. Since uptake of alkylating agents which are not freely lipid-soluble is proliferation-dependent (Byfield et al., 1979) and since sensitization by MX is S-phase (i.e. proliferation)-dependent (Roberts, 1978) , resting Go marrow or gastrointestinal stem cells might well be relatively unaffected by such combinations. The therapeutic ratio for such transported alkylating agents might thereby be increased by combination with a suitable MX.
However, if the MX are to be clinically useful, their pharmacokinetic and physiological toxicities must also be considered. The remarkable differences both quantitative and in clinical distribution of limiting toxicities of the 3 classical forms of MX, are indicated in Table II . Theophylline, the drug most commonly used, has a therapeutic optimum around 20 jug/ml and can be fatal at 50-100 [kg/ml (Ogilvie, 1978) . It can be estimated that the lethal level of caffeine is significantly higher, deaths from caffeine ingestion being extremely rare (Martindale, 1972 However, studies on the absorption, distribution and metabolism of theobromine indicate that it is probably absorbed as well as either caffeine or theophylline (Cornish & Christman, 1957) .
It has been reported that caffeine is rapidly metabolized in mammalian cells (Goth & Cleaver, 1976) . However, in vivo in man all the MX have relatively long halflives (Cornish & Christman, 1957) and fairly constant serum levels of at least one (theophylline) are routinely obtained clinically using oral tablets 3 times a day (Ogilvie, 1978) . Thus, catabolism in vivo would probably have no significant clinical implications in their therapeutic use.
The most important aspect of the potential use of the MX in cancer therapy is dose-limiting toxicity. This varies dramatically from agent to agent. Clinically, the lethal toxicity from theophylline is primarily cardiac, while the most troublesome toxicity from caffeine is CNS stimulation, which is rarely fatal. So far as can be determined, theobromine is relatively benign, the major complaints at the toxic level being gastrointestinal (Martindale, 1972) . Thus, profound differences in the physiological effects of the 3 MX exist, and such effects must be related Apart from tlheophylline, whichl has wiidespread use in bronchospasm aind congestive lheart failure, the methylated xanthines are not of great therapeutic usefulness, thouglh caffeine is widely used in over-thecounter preparations for colds, etc. Death from caffeine ingestion is exceedingly rare, and has not been reported in man for theobromine. Theophylline is also a relativTely safe agent, albeit with a limitedl therapeutie range. The lethal concenitration for theoph.ylline is fairly well (lefined, but can only be estimated for caffeine and is unknown for theobromine. Sensitization of cells to killing by alkylating agents requires a concentration of about 200 1kg/ml for all 3 agents, and this level must be maintained for between 12 and 24 h, depending on the cell cycle time since it must be present (luring the post-exposure S phase to be effective (Roberts, 1978) .
to the position of the various methyl groups (Fig. 1) . On the other hand, their influence on UV and alkylating-agent toxicity is relatively uniform, though some differences have been encountered (Murnane et al., 1981; Murnane, 1980) .
The salient feature of this overview is that the clinically limiting physiological toxicity of these MX agents appears to bear no relationship to their capacity to sensitize to alkylating agents. By comparing the level of MX required for sensitization of alkylating agents with the anticipated tolerated dose (Table II) , it seems likely that theobromine or some analogue might be the best agent. It seems unlikely that a sensitizing level (about 1mM or 200 Htg/ml) of either caffeine or theophylline could be achieved in man without intolerable toxicity.
In extensive reviews of the effects of MX on various cellular parameters, it is apparent that they vary significantly in their effects on different forms of cellular toxicity other than direct cell killing (Kihlman, 1974; Timson, 1975) . In our hands 1, 7 dimethylxanthine (paraxanthine, Fig.  1 ) is inactive. Methoxy modifications at the C-8 position do not appear to eliminate this type of DNA-related phenomenon . Some modifications, such as the addition of a 1-(5-oxyhexyl group) at the N-1 site (Fujimoto et al., 1976) produce a vasoactive drug (pentoxyphylline) which has retained sensitizing potential (Murnane, 1980) . Pentoxyphylline is well-tolerated clinically (Spriet et al., 1977) but whether sensitizing levels could be attained is as yet unknown.
In considering the clinical potential of MXs, another central problem lies in their mode of action in sensitizing cells to alkylating agents. Analogue development would be greatly facilitated if the structural requirements for sensitization were known. Relatively high concentrations (between 0 5 and 2mM, -100-400 ,tg/ml) have been used in most of the reported studies. It has been known for some time that caffeine, and presumably other MXs, will interact with DNA and DNA analogues, primarily at single-stranded regions, and it is generally hypothesized that the phenomenon being observed in living cells relates to the capacity of MX to "intercalate". However, the initial studies along these lines used very high MX concentrations (Ts'o & Lu, 1964) and this mechanism may or may not be related (Lang, 1975 (Lang, , 1976 to what is observed in terms of cell survival. On the other hand, it is also well established that MX, especially caffeine, can inhibit the phosphodiesterases (Beavo et al., 1970) involved in the degradation of cyclic nucleotides, i.e. the intracellular messengers con-trolling a wide variety of phenomena not related to survival per se. Thus, MX might exert some of their sensitizing effects through physiological rather than biophysical mechanisms. Some evidence against such a role for cyclic nucleotides has been published (Ehmann et al., 1976) but only biophysical data were given, and it is not known whether or not the MX or related compounds exerted toxic effects on the cells studied.
From the studies reported here and elsewhere (Murnane, 1980; Murnane et al., 1980) a clearer picture of the mechanism by which MXs sensitize seems to be emerging. As noted above, it was initially proposed that caffeine inhibited "postreplication repair" in a variety of cell strains, which is tantamount to inhibiting some component of DNA synthesis, i.e. by-pass replication. On the other hand, there is good evidence (Roberts et al., 1974; Roberts & Ward, 1973 ) that under some conditions caffeine releases the block of replication induced by some alkylating agents. In our own laboratory the enhancement (or restoration) by MX of DNA synthesis following its inhibition by alkylating agents has been confirmed (Murnane et al., 1980) and occurs in both rodent and human cells. Since one of the most striking effects of either radiation (UV and X-ray) or alkylating-agent exposure is an abrupt inhibition of DNA synthesis, it seems likely that suppression of replicon initiation is a protective mechanism with selective advantage. Elsewhere (Murnane et al., 1980) we have shown that MXs appear to reverse this protective inhibition and permit the cell to resume DNA synthesis under conditions which lead to enhanced cell death. We feel therefore that the mechanism of sensitization by MX does not relate to either effects on cyclic nucleotide metabolism or DNA repair per se but rather on the capacity to reverse the protective effects of replication inhibition. If this interpretation is correct, then it is apparent that a new group of useful agents may exist, viz. drugs which modify intracellular DNA replication dynamics within the individual cell cycle.
To summarize (and acknowledging some ambiguities in the existing literature), caffeine appears deleteriously to restore both DNA replication and enzymatic repair mechanisms, allowing them to proceed when ordinarily they would be inhibited. This facilitation has been shown to proceed when ordinarily they would be inhibited. This facilitation has been shown to occur in cells exposed to both alkylating agents (Roberts, 1978; Roberts & Ward, 1973) and X-rays (Snyder et al., 1977; Tolmach et al., 1977; Waldren & Rasko, 1978) . Contrary to what is commonly stated, caffeine seems actually to stimulate DNA excision repair rather than inhibit it (cf. data in Cleaver, 1969; Regan et al., 1968; Roberts & Ward, 1973) . When assayed as "post-replication repair", especially after UV, the effect of MX is transiently inhibitory, but even in this case the eventual effect is to cause cells to pass through S phase and this transit is deleterious in terms of cell survival. For these reasons we favour the idea (first suggested by Dr R. B. Painter) that caffeine and its analogues may well produce their sensitizing effects by deranging the normal physiological processes involving normal cellular repair systems, most probably by releasing the cell from protective DNA confirmational changes induced by monofilar alkylations, in a such way that the cell proceeds with lethal replicon initiation. If this interpretation is correct, it is apparent that excision repair may be an important part of what is called "potentially lethal damage". The conclusions of Fraval & Roberts (1979) on the excision of cis-Diamminedichloroplatinum (II) DNA adducts (which was associated with increased survival) are in accord with this interpretation.
For several reasons it seems plausible that sensitization to alkylating agents might be clinically feasible using one or more forms of MX. Since "modern" chemotherapy often uses intermittent high-dose pulse therapy, sensitization of tumour cells to the classical water-soluble alkylating agents (melphalan, nitrogen mustard, cyclophosphamide, etc.) appears most reasonable since such agents show relative marrow sparing, and this appears to be based on the transport-dependent exclusion of such drugs from resting normal stem cells (Byfield et al., 1979) . It must be emphasized that rodent assays may be confusing in testing these premises because of their reduced ability to excise the relevant damage. Nevertheless, in vivo rodent assays using caffeine have already shown some "beneficial" sensitization (Gaudin & Yielding, 1969; Cohen, 1972; Cohen & Carbone, 1972) , though this is to be expected from the enhanced sensitivity of excision-deficient rodent DNA repair pathways. Even human tumours in athymic mice probably cannot be used to determine therapeutic usefulness, since the dose-limiting normal rodent tissues would be expected to be more sensitive than the repair-competent human tumour target cells. Homo sapiens may have to stand on his own 2 feet to test these intriguing possibilities!
